سواليف
سواليف
Ready to play
Ready to play
A recent study from Monash University has revealed that taking low doses of aspirin may reduce the risk of developing dementia among seniors who carry genetic traits associated with platelet count. The results showed that only 1% of participants with the highest genetic markers related to platelets who took aspirin developed dementia, compared to 3.3% of those who took a placebo, representing a roughly 70% reduction in dementia risk. However, aspirin was also linked to an increased risk of severe bleeding, with 4.4% of users experiencing major hemorrhages compared to 2.1% of non-users. The researchers emphasized that these findings highlight the importance of studying the role of platelets in dementia, though further research is needed to confirm them. They also warned that anyone considering aspirin for this purpose should consult a doctor, as it may be beneficial only for individuals carrying these specific genetic patterns.
Notice: This Is an AI-Generated Summary
Comments (0)